- AdventHealth
Having breast cancer can be overwhelming and confusing, especially trying to understand treatment options. The goal of one program available to AdventHealth patients is to make it easy for patients to understand their treatment journey. The Breast Multidisciplinary Clinic (MDC) is improving patient outcomes by functioning as a functioning as a collaborative team with providers practicing the most up-to-date guidelines and cutting-edge science to deliver the best and most recent treatment to patients, which has exceeded the national average. It’s also focused on providing a better patient experience, such as lowering stress by providing a one-stop shop for patients to meet their breast cancer team all at once, which means less trips and faster time to treatment.
“It was so devastating,” said Simona Lazinsk, who was diagnosed with breast cancer five years ago at 42. “I’m so grateful to still be alive and be here after five years. I can’t imagine if I didn’t go through the treatment and I didn’t have the support from my team of doctors, where I would be today,” she recently shared with WFTV – Channel 9 News.
“Every Monday afternoon, I dedicate my afternoon to seeing patients who have newly diagnosed breast cancer,” said Dr. Wassim Mchayleh, a medical oncologist at the AdventHealth Cancer Institute and one of Lazinsk’s physicians, recently told Becker’s Healthcare podcast. “I have a breast surgeon and radiation oncologist together – the advantage of this model is that the patient has a one-stop shop – they are diagnosed and then see their three specialists who are going to formulate a treatment plan for them.”
In addition to the three physicians, patients also work with a breast cancer navigator onsite as well as the genetics department to discuss and create, in real-time, a customized care plan.
“There is nothing better for a patient with a diagnosis of breast cancer than having a clear, unified plan,” said Dr. Wassim Mchayleh.
Lazinsk added, “Facing cancer treatment is overwhelming enough without the added stress of commuting between multiple offices.”
Dr. Mchayleh stresses the importance of maintaining regular screenings, the standard screening age for breast cancer is 40. He recently told The Healthy most cancers develop over a period of six to 12 months – the more aggressive types can emerge between regular mammogram screenings. Because of this, he warns it is essential to seek further evaluation if there are any changes, even after a negative mammogram.
“I’ve come to view these doctors (on my Breast MDC team) as family,” Lazinsk told The Healthy. “Life blooms, even after cancer.”
Lazinsk celebrated her five-year milestone of being cancer free last month.
The AdventHealth Breast MDC started in 2019. In that time, this innovative model has treated over 2,000 patients and expanded from Altamonte Springs to Orlando, Winter Park, Celebration and a fifth MDC will open later this year in Kissimmee. To learn more about the AdventHealth Breast MDC, click here.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...